Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 4, 2018
Event: Regulation FD Disclosure (Item 7.01) regarding an investor presentation furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references an investor presentation for use in meetings but does not summarize the content of that presentation within the 8-K body.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated June 2018 for use in meetings with investors or analysts.
Legal Status: The information in this report and its exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly referenced.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated June 2018) for actual financial data and strategic outlook.
- Verify if the investor presentation contains forward-looking statements that differ from prior guidance.
- Confirm the date of the investor presentation matches the filing date (June 4, 2018).